Gilde IT Fund

Gilde Healthcare, with a prominent office in Cambridge, Massachusetts, is a specialized venture and growth capital firm focused exclusively on the healthcare sector. While the name "Gilde IT Fund" might suggest a broader technology focus, Gilde Healthcare's investment mandate specifically targets innovative companies within digital health, health IT, medical devices, and therapeutics across Europe and the United States. The firm is part of the larger Gilde group, which boasts a rich history dating back to 1982 and has collectively invested in over 250 companies across its various funds. Gilde Healthcare itself was established in 1999, building a strong reputation for its deep industry expertise and extensive network.

The firm manages substantial capital, with its latest fund, Gilde Healthcare VI, successfully closing at €580 million (approximately $626 million) in 2023. This significant capital base enables Gilde Healthcare to support companies from early-stage development through to commercialization. They typically engage in Series A, B, and C funding rounds, providing both capital and strategic guidance to help portfolio companies scale and achieve their market potential. Their investment strategy is characterized by a hands-on approach, partnering with management teams to accelerate growth and navigate complex healthcare landscapes.

Gilde Healthcare's initial cheque sizes for new investments typically range from approximately $5 million to $20 million. However, the firm has the capacity to deploy significantly more capital over the lifecycle of an investment, with total commitments per company potentially reaching up to €60 million. This flexibility allows them to support promising ventures through multiple financing rounds as they achieve key milestones. With offices in Utrecht (Netherlands), Frankfurt (Germany), and Cambridge (USA), Gilde Healthcare is strategically positioned to identify and support leading healthcare innovations on both sides of the Atlantic, fostering advancements that address critical medical needs.